Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Currency in USD	2025
Operating Income	479.82 Million
Income Before Tax	605.07 Million
Income Tax Expense	67.20 Million
Net Income	537.87 Million
Eps	3.98
Epsdiluted	3.92
Weighted Average Shs Out	135.22 Million
Weighted Average Shs Out Dil	137.06 Million
Research And Development Expenses	147.25 Million
Selling General And Administrative Expenses	1.18 Billion
Depreciation And Amortization	276.84 Million
Interest Expense	N/A
Interest Income	N/A
Net Interest Income	7.14 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	1.98 Billion
Ebitda	756.66 Million
Source	edgar
Ebit	537.19 Million

Globus Medical, Inc. Annual Reports (10-K)